ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. - Cheli Y; Tulic MK; El Hachem N; Nottet N; Jacquel A; Gesson M; Strub T; Bille K; Picard-Gauci A; Montaudié H; Beranger GE; Passeron T; et al. (Molecular cancer, 2021)